Hydrogenology
Source-linked study record

Hydrogen-rich water exerting a protective effect on ovarian reserve function in a mouse model of immune premature ovarian failure induced by zona pellucida 3

He X, Wang SY, Yin CH, Wang T, Jia CW, Ma YM. · Chinese Medical Journal. 2016;129(19):2331–2337.

PreclinicalH₂-rich waterPublished 2016Source checked
Study record, not medical adviceThis record reports what the source states. It is not medical advice and does not establish that molecular hydrogen is effective, safe or appropriate for any person.
Quick summary

Study at a glance

Evidence type

Preclinical

Population or model

50 adult female BALB/c mice with normal estrous cycles, with or without zona-pellucida-3 immunization.

Intervention and dose

H₂-rich water offered four times daily; mice drank about 0.9 mL at each offering for five weeks. · H₂ was dissolved into 200 mL water at 230 mL/min for 20 minutes; concentration was confirmed above 0.8 mmol/L before and after each 4.5-hour interval.

Duration

Five weeks from first immunization through tissue collection; water offered every 4.5 hours, four times/day.

Reported result

Anti-Müllerian hormone, granulosa-cell apoptosis and Bcl-2 favored H₂ water in injured mice. Estrous cycling remained incompletely regular, Bax did not differ significantly, and the Bax/Bcl-2 ratio difference was not statistically significant.

Main limitation

Small mouse model, prophylaxis and disease induction occurred concurrently, no fertility/pregnancy endpoint, limited mechanism and no translation of dose to people. Beijing public/hospital grants funded the work; authors declared no conflicts and identified the commercial H₂-generator manufacturer.

Evidence and classification

What kind of evidence is this?

Evidence type

Preclinical

Reported design

Randomized four-group mouse immune-ovarian-injury experiment

Research topic

Women’s health

Administration form

H₂-rich water

Information not yet classified

Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.

Reported in the source

Methods

Population or model

50 adult female BALB/c mice with normal estrous cycles, with or without zona-pellucida-3 immunization.

Sample

Control n=10, H₂ water without injury n=10, ovarian-injury model n=15 and model plus H₂ water n=15.

Duration

Five weeks from first immunization through tissue collection; water offered every 4.5 hours, four times/day.

Intervention

H₂-rich water offered four times daily; mice drank about 0.9 mL at each offering for five weeks.

Hydrogen form

H₂ dissolved in drinking water — H₂ only, not Brown's gas and not inhalation.

Dose or H₂ specification

H₂ was dissolved into 200 mL water at 230 mL/min for 20 minutes; concentration was confirmed above 0.8 mmol/L before and after each 4.5-hour interval.

Comparator

Normal water with and without zona-pellucida-3 immunization, plus H₂ water without ovarian injury.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Estrous cyclicity, serum anti-Müllerian hormone, granulosa-cell apoptosis and ovarian Bax/Bcl-2 immunostaining and protein expression.

Reported result

Anti-Müllerian hormone, granulosa-cell apoptosis and Bcl-2 favored H₂ water in injured mice. Estrous cycling remained incompletely regular, Bax did not differ significantly, and the Bax/Bcl-2 ratio difference was not statistically significant.

Extraction completeness

The complete free PMC article, figures and methods were checked for randomization, exact preparation flow/concentration and intake, all groups, positive and null ovarian outcomes, limitations, funding and conflicts.

A reported association, difference or mechanism is not automatically a clinical benefit.

Interpretation limits

Limitations and applicability

Main methodological cautions

Small mouse model, prophylaxis and disease induction occurred concurrently, no fertility/pregnancy endpoint, limited mechanism and no translation of dose to people. Beijing public/hospital grants funded the work; authors declared no conflicts and identified the commercial H₂-generator manufacturer.

Applies directly to

Immune ovarian injury in mice; it does not establish preservation or restoration of ovarian reserve or fertility in people.

No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.

Sources and status

Sources and record status

Identifiers

PMID: 27647193 · DOI: 10.4103/0366-6999.190668

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Last reviewed

10 August 2026

Help the next reader

Help people check the facts before they buy.

Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.

Support independent access
Help us correct the recordReport a discrepancy

Send the exact difference between this page and the linked source. The study reference is attached automatically.